| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | benzodiazepine receptor binding | 5.93e-07 | 5 | 79 | 3 | GO:0030156 | |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | ZNF729 OTX1 ZNF680 ZNF678 PITX1 BACH1 NR5A2 ZNF507 MECOM NKX2-5 ZNF322 MAFB NR1D1 ZBTB24 NR1D2 MAF | 2.42e-05 | 1244 | 79 | 16 | GO:0000978 |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | ZNF729 OTX1 ZNF680 ZNF678 PITX1 BACH1 NR5A2 ZNF507 MECOM NKX2-5 ZNF322 MAFB NR1D1 ZBTB24 NR1D2 MAF | 3.14e-05 | 1271 | 79 | 16 | GO:0000987 |
| GeneOntologyMolecularFunction | ligand-activated transcription factor activity | 9.98e-05 | 61 | 79 | 4 | GO:0098531 | |
| GeneOntologyMolecularFunction | DNA-binding transcription factor activity, RNA polymerase II-specific | ZNF729 OTX1 ZNF680 ZNF678 PITX1 BACH1 NR5A2 ZNF507 MECOM NKX2-5 ZNF322 MAFB NR1D1 ZBTB24 NR1D2 MAF | 1.10e-04 | 1412 | 79 | 16 | GO:0000981 |
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | ZNF729 OTX1 ZNF680 ZNF678 PITX1 BACH1 NR5A2 ZNF507 MECOM NKX2-5 ZNF322 MAFB NR1D1 ZBTB24 NR1D2 MAF | 1.61e-04 | 1459 | 79 | 16 | GO:0000977 |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity, RNA polymerase II-specific | 3.62e-04 | 560 | 79 | 9 | GO:0001228 | |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity | 3.91e-04 | 566 | 79 | 9 | GO:0001216 | |
| GeneOntologyMolecularFunction | dynein light chain binding | 9.94e-04 | 12 | 79 | 2 | GO:0045503 | |
| GeneOntologyMolecularFunction | mismatched DNA binding | 1.36e-03 | 14 | 79 | 2 | GO:0030983 | |
| GeneOntologyMolecularFunction | insulin receptor substrate binding | 1.57e-03 | 15 | 79 | 2 | GO:0043560 | |
| GeneOntologyMolecularFunction | nuclear receptor activity | 1.73e-03 | 60 | 79 | 3 | GO:0004879 | |
| GeneOntologyMolecularFunction | dynein heavy chain binding | 2.02e-03 | 17 | 79 | 2 | GO:0045504 | |
| GeneOntologyCellularComponent | manchette | 1.59e-04 | 28 | 79 | 3 | GO:0002177 | |
| Domain | bZIP_Maf | 2.02e-05 | 13 | 79 | 3 | IPR004826 | |
| Domain | bZIP_Maf | 2.02e-05 | 13 | 79 | 3 | PF03131 | |
| Domain | VitD_rcpt | 2.56e-05 | 14 | 79 | 3 | IPR000324 | |
| Domain | - | 3.92e-05 | 16 | 79 | 3 | 1.10.880.10 | |
| Domain | Maf_N | 1.05e-04 | 4 | 79 | 2 | PF08383 | |
| Domain | Maf_TF_N | 1.05e-04 | 4 | 79 | 2 | IPR013592 | |
| Domain | Transciption_factor_Maf_fam | 3.66e-04 | 7 | 79 | 2 | IPR024874 | |
| Domain | TF_DNA-bd | 5.10e-04 | 37 | 79 | 3 | IPR008917 | |
| Domain | zf-C4 | 9.70e-04 | 46 | 79 | 3 | PF00105 | |
| Domain | Znf_hrmn_rcpt | 9.70e-04 | 46 | 79 | 3 | IPR001628 | |
| Domain | Nuclear_hrmn_rcpt | 9.70e-04 | 46 | 79 | 3 | IPR001723 | |
| Domain | NUCLEAR_REC_DBD_2 | 9.70e-04 | 46 | 79 | 3 | PS51030 | |
| Domain | NUCLEAR_REC_DBD_1 | 9.70e-04 | 46 | 79 | 3 | PS00031 | |
| Domain | ZnF_C4 | 9.70e-04 | 46 | 79 | 3 | SM00399 | |
| Domain | - | 1.03e-03 | 47 | 79 | 3 | 1.10.565.10 | |
| Domain | HOLI | 1.10e-03 | 48 | 79 | 3 | SM00430 | |
| Domain | Nucl_hrmn_rcpt_lig-bd | 1.10e-03 | 48 | 79 | 3 | IPR000536 | |
| Domain | Hormone_recep | 1.10e-03 | 48 | 79 | 3 | PF00104 | |
| Domain | BRLZ | 1.39e-03 | 52 | 79 | 3 | SM00338 | |
| Domain | BZIP | 1.47e-03 | 53 | 79 | 3 | PS50217 | |
| Domain | BZIP_BASIC | 1.47e-03 | 53 | 79 | 3 | PS00036 | |
| Domain | ZINC_FINGER_C2H2_2 | ZNF729 ZNF680 ZNF678 APTX ZNF804B ZNF507 MECOM ZNF322 ZNF804A ZBTB24 | 1.55e-03 | 775 | 79 | 10 | PS50157 |
| Domain | bZIP | 1.55e-03 | 54 | 79 | 3 | IPR004827 | |
| Domain | ZINC_FINGER_C2H2_1 | ZNF729 ZNF680 ZNF678 APTX ZNF804B ZNF507 MECOM ZNF322 ZNF804A ZBTB24 | 1.58e-03 | 777 | 79 | 10 | PS00028 |
| Domain | - | 1.81e-03 | 57 | 79 | 3 | 3.30.50.10 | |
| Domain | Znf_NHR/GATA | 1.90e-03 | 58 | 79 | 3 | IPR013088 | |
| Domain | Znf_C2H2 | ZNF729 ZNF680 ZNF678 APTX ZNF804B ZNF507 MECOM ZNF322 ZNF804A ZBTB24 | 2.04e-03 | 805 | 79 | 10 | IPR007087 |
| Domain | ZnF_C2H2 | ZNF729 ZNF680 ZNF678 APTX ZNF804B ZNF507 MECOM ZNF322 ZNF804A ZBTB24 | 2.10e-03 | 808 | 79 | 10 | SM00355 |
| Domain | - | 3.52e-03 | 21 | 79 | 2 | 3.30.230.10 | |
| Domain | Ribosomal_S5_D2-typ_fold_subgr | 3.86e-03 | 22 | 79 | 2 | IPR014721 | |
| Domain | Znf_C2H2_jaz | 3.86e-03 | 22 | 79 | 2 | IPR022755 | |
| Domain | zf-C2H2_jaz | 3.86e-03 | 22 | 79 | 2 | PF12171 | |
| Domain | SH3_9 | 4.41e-03 | 78 | 79 | 3 | PF14604 | |
| Domain | WD40 | 4.83e-03 | 259 | 79 | 5 | PF00400 | |
| Domain | WD40 | 5.57e-03 | 268 | 79 | 5 | SM00320 | |
| Domain | SH3_2 | 5.79e-03 | 86 | 79 | 3 | IPR011511 | |
| Domain | SH3_2 | 5.79e-03 | 86 | 79 | 3 | PF07653 | |
| Domain | WD40_repeat | 5.92e-03 | 272 | 79 | 5 | IPR001680 | |
| Domain | Znf_C2H2-like | ZNF729 ZNF680 APTX ZNF804B ZNF507 MECOM ZNF322 ZNF804A ZBTB24 | 6.34e-03 | 796 | 79 | 9 | IPR015880 |
| Domain | WD_REPEATS_1 | 6.49e-03 | 278 | 79 | 5 | PS00678 | |
| Domain | WD_REPEATS_2 | 6.58e-03 | 279 | 79 | 5 | PS50082 | |
| Domain | WD_REPEATS_REGION | 6.58e-03 | 279 | 79 | 5 | PS50294 | |
| Pubmed | RIM-BP3 is a manchette-associated protein essential for spermiogenesis. | 4.68e-08 | 4 | 80 | 3 | 19091768 | |
| Pubmed | Structure and evolution of RIM-BP genes: identification of a novel family member. | 1.17e-07 | 5 | 80 | 3 | 17855024 | |
| Pubmed | 2.33e-07 | 6 | 80 | 3 | 33897412 | ||
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | LONP1 CDK5RAP3 HNRNPUL2 UTP11 SYNE1 DTL DYNC2I1 RNF213 PNPLA8 ATXN10 PFKM SUCO NDUFB10 WDR62 RHOT1 ZC3HAV1 | 2.53e-07 | 1496 | 80 | 16 | 32877691 |
| Pubmed | ZNF729 OTX1 RHOBTB3 BACH1 NR5A2 ZNF507 ING5 ZNF322 NR1D1 ZBTB24 NR1D2 ZC3HAV1 | 3.23e-07 | 808 | 80 | 12 | 20412781 | |
| Pubmed | A Y2H-seq approach defines the human protein methyltransferase interactome. | 1.26e-06 | 342 | 80 | 8 | 23455924 | |
| Pubmed | Integrative characterization of germ cell-specific genes from mouse spermatocyte UniGene library. | 4.19e-06 | 14 | 80 | 3 | 17662146 | |
| Pubmed | Circadian clock protein Rev-erbα regulates neuroinflammation. | 5.23e-06 | 2 | 80 | 2 | 30792350 | |
| Pubmed | 5.23e-06 | 2 | 80 | 2 | 32798635 | ||
| Pubmed | Epidermal differentiation gene regulatory networks controlled by MAF and MAFB. | 5.23e-06 | 2 | 80 | 2 | 27097296 | |
| Pubmed | Reverse Erythroblastosis Virus α Antagonism Promotes Homocysteine Catabolism and Ammonia Clearance. | 5.23e-06 | 2 | 80 | 2 | 31016736 | |
| Pubmed | 5.23e-06 | 2 | 80 | 2 | 38142970 | ||
| Pubmed | Identification of heme as the ligand for the orphan nuclear receptors REV-ERBalpha and REV-ERBbeta. | 5.23e-06 | 2 | 80 | 2 | 18037887 | |
| Pubmed | SR9009 has REV-ERB-independent effects on cell proliferation and metabolism. | 5.23e-06 | 2 | 80 | 2 | 31127047 | |
| Pubmed | 5.23e-06 | 2 | 80 | 2 | 32439175 | ||
| Pubmed | 5.23e-06 | 2 | 80 | 2 | 29723273 | ||
| Pubmed | 5.23e-06 | 2 | 80 | 2 | 15249232 | ||
| Pubmed | Rev-erbα and Rev-erbβ coordinately protect the circadian clock and normal metabolic function. | 5.23e-06 | 2 | 80 | 2 | 22474260 | |
| Pubmed | MafB/c-Maf deficiency enables self-renewal of differentiated functional macrophages. | 5.23e-06 | 2 | 80 | 2 | 19892988 | |
| Pubmed | SR9009 improves heart function after pressure overload independent of cardiac REV-ERB. | 5.23e-06 | 2 | 80 | 2 | 35911512 | |
| Pubmed | MAFB and MAF Transcription Factors as Macrophage Checkpoints for COVID-19 Severity. | 5.23e-06 | 2 | 80 | 2 | 33312178 | |
| Pubmed | 5.23e-06 | 2 | 80 | 2 | 33021965 | ||
| Pubmed | 5.23e-06 | 2 | 80 | 2 | 33012117 | ||
| Pubmed | Impact of circadian nuclear receptor REV-ERBα on midbrain dopamine production and mood regulation. | 5.23e-06 | 2 | 80 | 2 | 24813609 | |
| Pubmed | 5.23e-06 | 2 | 80 | 2 | 20348464 | ||
| Pubmed | The hepatocyte clock and feeding control chronophysiology of multiple liver cell types. | 5.23e-06 | 2 | 80 | 2 | 32732282 | |
| Pubmed | 5.23e-06 | 2 | 80 | 2 | 38255844 | ||
| Pubmed | 5.23e-06 | 2 | 80 | 2 | 20060689 | ||
| Pubmed | Phosphorylation of N-terminal regions of REV-ERBs regulates their intracellular localization. | 5.23e-06 | 2 | 80 | 2 | 29508494 | |
| Pubmed | 5.23e-06 | 2 | 80 | 2 | 31800167 | ||
| Pubmed | Differential expression patterns of MafB and c-Maf in macrophages in vivo and in vitro. | 5.23e-06 | 2 | 80 | 2 | 26996125 | |
| Pubmed | A census of human transcription factors: function, expression and evolution. | OTX1 PITX1 BACH1 NR5A2 NKX2-5 ZNF322 MAFB NR1D1 ZBTB24 NR1D2 MAF | 7.34e-06 | 908 | 80 | 11 | 19274049 |
| Pubmed | REV-ERBα Regulates CYP7A1 Through Repression of Liver Receptor Homolog-1. | 1.57e-05 | 3 | 80 | 2 | 29237721 | |
| Pubmed | 1.57e-05 | 3 | 80 | 2 | 23071278 | ||
| Pubmed | 1.57e-05 | 3 | 80 | 2 | 8910607 | ||
| Pubmed | REV-ERBα and REV-ERBβ function as key factors regulating Mammalian Circadian Output. | 1.57e-05 | 3 | 80 | 2 | 31308426 | |
| Pubmed | 1.57e-05 | 3 | 80 | 2 | 19308255 | ||
| Pubmed | 1.57e-05 | 3 | 80 | 2 | 8948627 | ||
| Pubmed | Hepatocyte SREBP signaling mediates clock communication within the liver. | 1.57e-05 | 3 | 80 | 2 | 37066875 | |
| Pubmed | 1.57e-05 | 3 | 80 | 2 | 34705514 | ||
| Pubmed | 1.57e-05 | 3 | 80 | 2 | 9482666 | ||
| Pubmed | 1.57e-05 | 3 | 80 | 2 | 18454201 | ||
| Pubmed | MafB promotes atherosclerosis by inhibiting foam-cell apoptosis. | 1.57e-05 | 3 | 80 | 2 | 24445679 | |
| Pubmed | 1.57e-05 | 3 | 80 | 2 | 29401617 | ||
| Pubmed | 1.57e-05 | 3 | 80 | 2 | 17892483 | ||
| Pubmed | The opportunistic human pathogenic fungus Aspergillus fumigatus evades the host complement system. | 1.57e-05 | 3 | 80 | 2 | 18039838 | |
| Pubmed | Inhibition of the deubiquitinase USP5 leads to c-Maf protein degradation and myeloma cell apoptosis. | 3.13e-05 | 4 | 80 | 2 | 28933784 | |
| Pubmed | Ubiquitin ligase Siah2 regulates RevErbα degradation and the mammalian circadian clock. | 3.13e-05 | 4 | 80 | 2 | 26392558 | |
| Pubmed | The nuclear receptor REV-ERBα modulates Th17 cell-mediated autoimmune disease. | 3.13e-05 | 4 | 80 | 2 | 31455731 | |
| Pubmed | 3.13e-05 | 4 | 80 | 2 | 32342250 | ||
| Pubmed | Regulation of circadian behaviour and metabolism by REV-ERB-α and REV-ERB-β. | 3.13e-05 | 4 | 80 | 2 | 22460952 | |
| Pubmed | Cross-talk among ROR alpha 1 and the Rev-erb family of orphan nuclear receptors. | 3.13e-05 | 4 | 80 | 2 | 7838158 | |
| Pubmed | Myocardial Rev-erb-Mediated Diurnal Metabolic Rhythm and Obesity Paradox. | 3.13e-05 | 4 | 80 | 2 | 35034472 | |
| Pubmed | 3.13e-05 | 4 | 80 | 2 | 17901057 | ||
| Pubmed | 3.13e-05 | 4 | 80 | 2 | 32452758 | ||
| Pubmed | Circadian lipid synthesis in brown fat maintains murine body temperature during chronic cold. | 3.13e-05 | 4 | 80 | 2 | 31451658 | |
| Pubmed | 3.13e-05 | 4 | 80 | 2 | 36763533 | ||
| Pubmed | 5.20e-05 | 5 | 80 | 2 | 20547088 | ||
| Pubmed | Circadian clock component REV-ERBα controls homeostatic regulation of pulmonary inflammation. | 5.20e-05 | 5 | 80 | 2 | 29533925 | |
| Pubmed | 5.20e-05 | 5 | 80 | 2 | 12917329 | ||
| Pubmed | Time-Restricted Feeding Prevents Obesity and Metabolic Syndrome in Mice Lacking a Circadian Clock. | 5.20e-05 | 5 | 80 | 2 | 30174302 | |
| Pubmed | 5.20e-05 | 5 | 80 | 2 | 27462873 | ||
| Pubmed | 5.20e-05 | 5 | 80 | 2 | 12970790 | ||
| Pubmed | CGRP sensory neurons promote tissue healing via neutrophils and macrophages. | 5.20e-05 | 5 | 80 | 2 | 38538784 | |
| Pubmed | GENE REGULATION. Discrete functions of nuclear receptor Rev-erbα couple metabolism to the clock. | 5.20e-05 | 5 | 80 | 2 | 26044300 | |
| Pubmed | IRS pleckstrin homology domains bind to acidic motifs in proteins. | 5.20e-05 | 5 | 80 | 2 | 9813005 | |
| Pubmed | 5.20e-05 | 5 | 80 | 2 | 26116826 | ||
| Pubmed | 6.08e-05 | 33 | 80 | 3 | 20102225 | ||
| Pubmed | 7.05e-05 | 95 | 80 | 4 | 24029230 | ||
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | 7.24e-05 | 774 | 80 | 9 | 15302935 | |
| Pubmed | Role of large MAF transcription factors in the mouse endocrine pancreas. | 7.79e-05 | 6 | 80 | 2 | 25912440 | |
| Pubmed | 7.79e-05 | 6 | 80 | 2 | 31586012 | ||
| Pubmed | 7.79e-05 | 6 | 80 | 2 | 18086663 | ||
| Pubmed | The Bach Family of Transcription Factors: A Comprehensive Review. | 7.79e-05 | 6 | 80 | 2 | 27052415 | |
| Pubmed | TH17 cell differentiation is regulated by the circadian clock. | 7.79e-05 | 6 | 80 | 2 | 24202171 | |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | FKBP15 PTPN11 HNRNPUL2 PTPRO DTL UGDH IRS2 ATXN10 PFKM ZC3HAV1 | 7.92e-05 | 974 | 80 | 10 | 28675297 |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | LONP1 PTPN11 HNRNPUL2 SYNE1 DOCK7 SNU13 SGO2 PNPLA8 CHD4 ATXN10 PFKM ZC3HAV1 | 9.78e-05 | 1425 | 80 | 12 | 30948266 |
| Pubmed | Networks of bZIP protein-protein interactions diversified over a billion years of evolution. | 1.09e-04 | 40 | 80 | 3 | 23661758 | |
| Pubmed | Neither MafA/L-Maf nor MafB is essential for lens development in mice. | 1.09e-04 | 7 | 80 | 2 | 19624757 | |
| Pubmed | Small Heterodimer Partner Regulates Circadian Cytochromes p450 and Drug-Induced Hepatotoxicity. | 1.09e-04 | 7 | 80 | 2 | 30555544 | |
| Pubmed | 1.20e-04 | 332 | 80 | 6 | 25693804 | ||
| Pubmed | 1.27e-04 | 650 | 80 | 8 | 38777146 | ||
| Pubmed | 1.45e-04 | 8 | 80 | 2 | 7894168 | ||
| Pubmed | 1.45e-04 | 8 | 80 | 2 | 15611085 | ||
| Pubmed | 1.45e-04 | 8 | 80 | 2 | 11036080 | ||
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | OTX1 APTX PITX1 BACH1 ING5 SNU13 MECOM CHD4 ZCCHC7 NDUFB10 ZC3HAV1 | 1.81e-04 | 1294 | 80 | 11 | 30804502 |
| Pubmed | MafB-restricted local monocyte proliferation precedes lung interstitial macrophage differentiation. | 1.86e-04 | 9 | 80 | 2 | 36928411 | |
| Pubmed | Reexpression of oncoprotein MafB in proliferative β-cells and Men1 insulinomas in mouse. | 1.86e-04 | 9 | 80 | 2 | 22120711 | |
| Pubmed | 1.86e-04 | 9 | 80 | 2 | 14701919 | ||
| Pubmed | Essential roles of ECAT15-2/Dppa2 in functional lung development. | 2.32e-04 | 10 | 80 | 2 | 21896782 | |
| Pubmed | Regulation of lens fiber cell differentiation by transcription factor c-Maf. | 2.32e-04 | 10 | 80 | 2 | 10383433 | |
| Pubmed | 2.34e-04 | 534 | 80 | 7 | 35032548 | ||
| Pubmed | Impact of cytosine methylation on DNA binding specificities of human transcription factors. | 2.61e-04 | 544 | 80 | 7 | 28473536 | |
| Pubmed | Common variants at 30 loci contribute to polygenic dyslipidemia. | 2.67e-04 | 54 | 80 | 3 | 19060906 | |
| Pubmed | PROTAC-mediated degradation reveals a non-catalytic function of AURORA-A kinase. | 2.70e-04 | 247 | 80 | 5 | 32989298 | |
| Pubmed | CHD4 is recruited by GATA4 and NKX2-5 to repress noncardiac gene programs in the developing heart. | 2.84e-04 | 11 | 80 | 2 | 35450884 | |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | HNRNPUL2 SYNE1 RASSF1 DTL BACH1 DYNC2I1 SNU13 SGO2 TIMELESS WDR62 | 3.14e-04 | 1155 | 80 | 10 | 20360068 |
| Pubmed | 3.24e-04 | 257 | 80 | 5 | 30945288 | ||
| Pubmed | 3.40e-04 | 12 | 80 | 2 | 20062060 | ||
| Pubmed | Molecular basis of pituitary dysfunction in mouse and human. | 3.40e-04 | 12 | 80 | 2 | 11420609 | |
| GeneFamily | Nuclear hormone receptors | 4.21e-04 | 49 | 54 | 3 | 71 | |
| GeneFamily | Basic leucine zipper proteins | 4.21e-04 | 49 | 54 | 3 | 506 | |
| GeneFamily | WD repeat domain containing | 1.09e-03 | 262 | 54 | 5 | 362 | |
| Coexpression | HORIUCHI_WTAP_TARGETS_UP | 4.73e-06 | 309 | 80 | 8 | M1973 | |
| Coexpression | GSE6269_E_COLI_VS_STREP_PNEUMO_INF_PBMC_UP | 1.33e-05 | 169 | 80 | 6 | M5661 | |
| Coexpression | BENPORATH_ES_WITH_H3K27ME3 | RIMBP3 COL24A1 OTX1 SYNE1 LPL PITX1 MECOM NKX2-5 MAFB RIMBP3C RIMBP3B TTLL7 PDZD2 | 3.10e-05 | 1115 | 80 | 13 | M10371 |
| Coexpression | GSE9988_LOW_LPS_VS_ANTI_TREM1_AND_LPS_MONOCYTE_DN | 3.16e-05 | 197 | 80 | 6 | M5865 | |
| Coexpression | GSE22589_HEALTHY_VS_SIV_INFECTED_DC_UP | 3.35e-05 | 199 | 80 | 6 | M7798 | |
| ToppCell | Bronchial_Brush-Epithelial-Ciliated_1|Bronchial_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.37e-06 | 194 | 80 | 6 | b4ce60c06568123008b1081d644733cb91c28f51 | |
| ToppCell | Bronchial_Brush-Epithelial-Ciliated_1|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.37e-06 | 194 | 80 | 6 | 7a7ddccfe72a4a0dc4d1a5c809988f0069f9f1a3 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.50e-06 | 197 | 80 | 6 | 91637bdeab85024b5a02d1066f76cb803a2d6420 | |
| ToppCell | NS-moderate-d_0-4-Epithelial-Ciliated|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.50e-06 | 197 | 80 | 6 | 71fea4aa6ce96c7693fa94792d08770622873850 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.50e-06 | 197 | 80 | 6 | 22c87dd15dc57bd0aa98a204c9fc9b3b9b573b45 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.50e-06 | 197 | 80 | 6 | 3bbf068d2ad8196fbc85d3f311a7c54c9aece856 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.50e-06 | 197 | 80 | 6 | 87db09f341e2b20eb6e1c3e917cb5c960387b3e9 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-2m-Mesenchymal-Unfolded_protein_responsible_cell|2m / Sample Type, Dataset, Time_group, and Cell type. | 1.64e-06 | 200 | 80 | 6 | 1b08c1be05e2a6a05d8ea35d9a745c4b1809a1b2 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Nr2f2_Necab1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.99e-06 | 124 | 80 | 5 | 298ff8bd8f0459f44ce8a8aea889c6f1cf84ac5f | |
| ToppCell | COVID-19-Heart-CM_5_(RYR2-)|Heart / Disease (COVID-19 only), tissue and cell type | 8.88e-06 | 155 | 80 | 5 | d7e26696fd9c0a759524f331243db43059b33ed9 | |
| ToppCell | PBMC-Control-cDC_1|Control / Compartment, Disease Groups and Clusters | 9.16e-06 | 156 | 80 | 5 | 9b6c5bcac516a62bcc1f5be32ffa8c92735ef0bc | |
| ToppCell | facs-Marrow-T_cells-18m-Myeloid-promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.13e-05 | 163 | 80 | 5 | 30cd95d4f37bd54c1fde54960cb005db58bdd30c | |
| ToppCell | facs-Marrow-T_cells-18m-Myeloid-monocyte_+_promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.13e-05 | 163 | 80 | 5 | ab934cb986495adfc8dbe5a276577f2a8fb6ee03 | |
| ToppCell | facs-MAT-Fat-3m-Myeloid-macrophage|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.17e-05 | 164 | 80 | 5 | b81498c3934e0d52bf0329dc745e02966f9d8613 | |
| ToppCell | PND07-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.31e-05 | 168 | 80 | 5 | a1755afa2cc50960ba60e07d84d61be429cdea72 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.83e-05 | 180 | 80 | 5 | 1f1af4474f3f0ac3c0d6b1a6c875c354d36d8eec | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum_-18m-Mesenchymal-Ependyma|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.83e-05 | 180 | 80 | 5 | 729f0d7af573c7796d8e28e6eec3af2fc0bd33a2 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum_-18m-Mesenchymal-ependymal_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.83e-05 | 180 | 80 | 5 | 9ef79a7c60227e352ac166c7274adb31f585f5ca | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.6.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.93e-05 | 182 | 80 | 5 | 4234d0cc57b5266a5e03133c75c7918abe48465e | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Myeloid-Proliferating_Alveolar_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.98e-05 | 183 | 80 | 5 | 42dc31d587fbb9724b2f0be5ee8ed77233f67b86 | |
| ToppCell | droplet-Lung-3m-Hematologic-myeloid-alveolar_macrophage-proliferating_alveolar_macrophage|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.09e-05 | 185 | 80 | 5 | 57c1eb50a4456d20953e48d5dc3b0ea3d0d81b6d | |
| ToppCell | droplet-Tongue-nan-24m-Epithelial-suprabasal|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.14e-05 | 186 | 80 | 5 | 2913b5fd0617d024d600ba7015ec7b1961dade83 | |
| ToppCell | droplet-Spleen-nan-3m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.25e-05 | 188 | 80 | 5 | 1a3f95b4fd7611c634666761ddf21f1e58e56af8 | |
| ToppCell | Epithelial-Epithelial-D_(Ciliated)|Epithelial / shred on cell class and cell subclass (v4) | 2.25e-05 | 188 | 80 | 5 | 8f30535a32968a81a304315a49c0d90a77d36948 | |
| ToppCell | Nasal_Brush-Epithelial-Ciliated_2|Nasal_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.37e-05 | 190 | 80 | 5 | 9ce7df056bfb24d70db4c3c4a2c57d89115de877 | |
| ToppCell | Nasal_Brush-Epithelial-Ciliated_2|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.37e-05 | 190 | 80 | 5 | 833481ace2800354712e2ce709d5cdfd0aed3d42 | |
| ToppCell | Bronchial_Biopsy-Epithelial-Ciliated_1|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.49e-05 | 192 | 80 | 5 | be592e661367affced9ebe80849b466e6adb3a34 | |
| ToppCell | facs-Aorta-Heart-3m-Mesenchymal|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.49e-05 | 192 | 80 | 5 | 0dc1f46e40346ed0b286e53b106a812441575100 | |
| ToppCell | Bronchial_Biopsy-Epithelial-Ciliated_1|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.55e-05 | 193 | 80 | 5 | 0b62a6ddd7c42efd9f39781971d1438501e1fa8d | |
| ToppCell | droplet-Lung-LUNG-1m-Myeloid-Proliferating_Alveolar_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.62e-05 | 194 | 80 | 5 | effd38e51062b225ecabc7e1c50154e65495d559 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4|GI_small-bowel / Manually curated celltypes from each tissue | 2.62e-05 | 194 | 80 | 5 | 4547b57669be5d4f0de55175802ee04372288a6a | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.62e-05 | 194 | 80 | 5 | 4a2c127c90d1fefe604fcb9e796577d21b489dd6 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.68e-05 | 195 | 80 | 5 | 649fd2336e963f6a150d182a53ad5dd838ca80b1 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.68e-05 | 195 | 80 | 5 | d211a836cf711fdb91b10d512f09d462be937cc5 | |
| ToppCell | droplet-Lung-1m-Hematologic-myeloid-alveolar_macrophage-proliferating_alveolar_macrophage|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.68e-05 | 195 | 80 | 5 | c1435e61e4f0cf457f26ae436936048932ceb0db | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.68e-05 | 195 | 80 | 5 | 129ad5f4253ecb1a8477cc38773e6e91ea9570b0 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.68e-05 | 195 | 80 | 5 | 3e70ee987d66d450062d5df3d7c733ccc7344470 | |
| ToppCell | moderate-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.68e-05 | 195 | 80 | 5 | 3486eae5fdb062a75a907b896c9d7b396d2aa195 | |
| ToppCell | COVID-19-Epithelial-Ciliated_cells|Epithelial / Condition, Lineage and Cell class | 2.75e-05 | 196 | 80 | 5 | de7aa31354b019d7321a8ef965d59ce2e8b89276 | |
| ToppCell | lymphoid-T_cell-unlabelled(multiplets)|World / Lineage, cell class and subclass | 2.75e-05 | 196 | 80 | 5 | 78b006922307c154622d71fcbc79ae5eed3f4b23 | |
| ToppCell | facs-Aorta-Heart-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.75e-05 | 196 | 80 | 5 | 2029f58ce6a7b8c35d3a7496c3341391990909ce | |
| ToppCell | NS-control-d_0-4-Epithelial-Ciliated|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.75e-05 | 196 | 80 | 5 | d46ab80554dd3c1cc81e1938ea2acfd5e85c6d2a | |
| ToppCell | PSB-critical-LOC-Epithelial-Ciliated|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.82e-05 | 197 | 80 | 5 | 6865f4831eb23794fb88a8649d48d497bbae3f44 | |
| ToppCell | control-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.82e-05 | 197 | 80 | 5 | e453d085182364ca347cbcc9dc995c62c3353016 | |
| ToppCell | control-Epithelial-Ciliated|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.82e-05 | 197 | 80 | 5 | d4e963c1f82996371bf3d63578ee9fce8e00c5a8 | |
| ToppCell | critical-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.89e-05 | 198 | 80 | 5 | ee2c8385c0bf4ea9f5c9517b52cf131af3fbdd40 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Stem-like-OPC-like-OPC-like-E|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.89e-05 | 198 | 80 | 5 | 1847ce8c344c8a3e50f3cbbf758a38aba69f85b0 | |
| ToppCell | (10)_Ciliated|World / shred by cell type by condition | 3.03e-05 | 200 | 80 | 5 | 1b6a8025bd2746b626040058c122b1be3ab2fa61 | |
| ToppCell | Bronchus_Control_(B.)-Epithelial-TX-Ciliated|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 3.03e-05 | 200 | 80 | 5 | 6a2ccc71a0cbe04a542c379b28b5006de53981c3 | |
| ToppCell | Biopsy_Control_(H.)-Epithelial-Differentiating_Ciliated|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 3.03e-05 | 200 | 80 | 5 | a552a99f5e4fa00dfb7775e5a3e1f62f1530d104 | |
| ToppCell | (09)_Interm._secr.>cil.|World / shred by cell type by condition | 3.03e-05 | 200 | 80 | 5 | 3305e14dba12e94da42f0414fdc7a2c8caf0a183 | |
| ToppCell | COVID-19-Heart-Fib_+_CM|Heart / Disease (COVID-19 only), tissue and cell type | 3.72e-05 | 104 | 80 | 4 | 0b60a56a46f1fe3f8224ec6399d009a34a117a21 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Calb2_Necab1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 7.87e-05 | 126 | 80 | 4 | a4fc7ac4931d2fc8aa8196a62d809b698937aa9c | |
| ToppCell | droplet-Fat-Gat-18m-Mesenchymal-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.42e-05 | 132 | 80 | 4 | 4152529611eeacf0c547e2a134d5b98c45426b13 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Tac1_Htr1d|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.15e-04 | 139 | 80 | 4 | fe1657ef9aeda7c530dc7febcd3dcd0e1d5f8a48 | |
| ToppCell | facs-Marrow-T-cells-24m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.35e-04 | 145 | 80 | 4 | 4f8b188a93a038afbc7a446df8467ad544f5b1cb | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c09-SLC4A10|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.43e-04 | 147 | 80 | 4 | 9566398275cad79223db90ffe640830acf2db864 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Myh8_Etv1_|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.46e-04 | 148 | 80 | 4 | 4d43efee96a6493abd78e9ca41aab73db0c80626 | |
| ToppCell | Striatum-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Pvalb-Inhibitory_Neuron.Gad1Gad2.Pvalb-Rgs12_(Fast-spiking_interneuron,_Pvalb+/Rgs12+)|Striatum / BrainAtlas - Mouse McCarroll V32 | 1.64e-04 | 59 | 80 | 3 | d49a63218a045f3d032d135aee234a3269222abd | |
| ToppCell | Striatum-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Pvalb-Inhibitory_Neuron.Gad1Gad2.Pvalb-Rgs12_(Fast-spiking_interneuron,_Pvalb+/Rgs12+)-|Striatum / BrainAtlas - Mouse McCarroll V32 | 1.64e-04 | 59 | 80 | 3 | 2d77ae08fa9836bbae158a0e466806a5f9236b5e | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.66e-04 | 153 | 80 | 4 | 0307f10e772021ae68a42690634df458672a6df9 | |
| ToppCell | facs-Marrow-Granulocytes-3m-Hematologic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.75e-04 | 155 | 80 | 4 | cd2f3ad4f131588325a667b6724e530d821fbe30 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Lect1_Oxtr|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.75e-04 | 155 | 80 | 4 | 99e749f7075e2c64e9a0bf91009f95b6969197c8 | |
| ToppCell | facs-Marrow-Granulocytes-3m-Hematologic-MPP_Fraction_B|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.75e-04 | 155 | 80 | 4 | 9b26ade19488511c72b64335011d2dcd81e8f167 | |
| ToppCell | facs-Marrow-Granulocytes-3m-Hematologic-hematopoietic_stem_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.75e-04 | 155 | 80 | 4 | 4246709e27703b94529369abbed5763e4002e79d | |
| ToppCell | facs-Marrow-B-cells-24m-Myeloid-promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.84e-04 | 157 | 80 | 4 | 0966e347f8d32b13f8a3b3afba3f64637c69cdf9 | |
| ToppCell | facs-Marrow-B-cells-24m-Myeloid-monocyte_+_promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.84e-04 | 157 | 80 | 4 | 6ebfedd91d62c6d4aa8f046657a899a279f82ba2 | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Adenocarcinoma_Mixed_Subtype-2|TCGA-Lung / Sample_Type by Project: Shred V9 | 1.88e-04 | 158 | 80 | 4 | 9dea15b28f64206bac0e785df6f36a2cc9010ac7 | |
| ToppCell | Frontal_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)-Cplx3-Inhibitory_Neuron.Gad1Gad2.Cplx3-Crim1_(Neuron.Gad1Gad2.Cplx3-Crim1)-|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 1.90e-04 | 62 | 80 | 3 | 91c49ae176d2a418a58398e9d5e55c77187cc2fb | |
| ToppCell | Frontal_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)-Cplx3-Inhibitory_Neuron.Gad1Gad2.Cplx3-Crim1_(Neuron.Gad1Gad2.Cplx3-Crim1)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 1.90e-04 | 62 | 80 | 3 | 3275775572a65460b6248ee72b4c85e4d4dee424 | |
| ToppCell | PND07-28-samps-Myeloid-Macrophage-macrophage-B|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 1.97e-04 | 160 | 80 | 4 | 694bf1f1952bd8ab444819f533da24fa2b73f701 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Calb2_Pdlim5|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.97e-04 | 160 | 80 | 4 | dd16ca90feb3ae88b6409d6c278b4765da565514 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Calb2_Pdlim5|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.02e-04 | 161 | 80 | 4 | bf70be1de418615b5442ec684552551edaf1f072 | |
| ToppCell | facs-MAT-Fat-3m-Myeloid-nan|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.17e-04 | 164 | 80 | 4 | 1250876abd7311f86730e5b9c03c3610cc2ff6d3 | |
| ToppCell | facs-MAT-Fat-3m-Myeloid|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.17e-04 | 164 | 80 | 4 | fa0d77b648cde5e42b9394e877168c80de238bde | |
| ToppCell | facs-Heart-LA-18m-Myeloid-monocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.22e-04 | 165 | 80 | 4 | be7e18d798e81e4b0f3080054aa222c6913e350b | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.22e-04 | 165 | 80 | 4 | eec2d327c94832d1390314c93ef6a2be4648478b | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.22e-04 | 165 | 80 | 4 | 88681101d7cf60b99b8ace5d8c0944323b937306 | |
| ToppCell | facs-Heart-LA-18m-Myeloid-monocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.22e-04 | 165 | 80 | 4 | 941a5b95164eaea47c3e6376e358f94c15b98312 | |
| ToppCell | facs-Lung-Endomucin-3m-Myeloid-Myeloid_Dendritic_Type_2|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.27e-04 | 166 | 80 | 4 | a2ce44702a0cd5fa5872cac3302d3c451205feef | |
| ToppCell | droplet-Spleen-nan-18m-Hematologic-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.27e-04 | 166 | 80 | 4 | e841e62cb20235d6233f78f4155fb8c0ffb1ef1b | |
| ToppCell | Dendritic_Cells-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 2.27e-04 | 166 | 80 | 4 | fbeb74b98b58085de323f744b18d4a8f7b22d5d4 | |
| ToppCell | facs-Lung-Endomucin-3m-Myeloid-myeloid_dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.27e-04 | 166 | 80 | 4 | 0f641302a6b71c4badaaf20f51162bfc2386b167 | |
| ToppCell | droplet-Marrow-nan-24m-Lymphocytic-plasma_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.27e-04 | 166 | 80 | 4 | b3d9b61847c6c96b8cb28b8a6aeda52f43c706ab | |
| ToppCell | droplet-Spleen-nan-18m-Hematologic|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.27e-04 | 166 | 80 | 4 | 3ca3ddb663644f0e7f70f9b75833bb54cd9191d3 | |
| ToppCell | droplet-Spleen-nan-18m-Hematologic-proerythroblast|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.27e-04 | 166 | 80 | 4 | f751cbd01d4978ded7755874ab60504f6291afd7 | |
| ToppCell | 356C-Myeloid-Macrophage-FABP4+_Macrophage|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 2.27e-04 | 166 | 80 | 4 | 89e2b8453180983533faccb4275867861876d7ee | |
| ToppCell | lung-Ciliated_Epithelia|lung / shred on tissue and cell subclass | 2.32e-04 | 167 | 80 | 4 | 26cf1cfa58ee74794449a87eb19cd896e1ec8892 | |
| ToppCell | droplet-Heart-HEART_(LV+RV_ONLY)-30m-Hematologic|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.32e-04 | 167 | 80 | 4 | eadb2c2650132446f0d0413792c69a4961ebc350 | |
| ToppCell | Posterior_cortex-Neuronal-Inhibitory|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 2.32e-04 | 167 | 80 | 4 | 9a84f45345c75f2c8ff38a04245aadee2a26a240 | |
| ToppCell | droplet-Heart-nan-3m-Hematologic-leukocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.32e-04 | 167 | 80 | 4 | 47447bcf184b1ad24ef17e135199fe7cd1d73c02 | |
| ToppCell | droplet-Heart-nan-24m-Hematologic|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.38e-04 | 168 | 80 | 4 | 0d505ddda32141b81173daecad11ca6b091688a9 | |
| ToppCell | facs-Liver-Non-hepatocytes-24m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.38e-04 | 168 | 80 | 4 | 95416f352801ce42cc317565e7dfb00478c593e1 | |
| ToppCell | 5'-Adult-LymphNode-Hematopoietic-Plasma_cells-IgG_plasma_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.38e-04 | 168 | 80 | 4 | f5a18123f84c62211d9279e9c41e90122e4c4895 | |
| ToppCell | facs-Heart-RV-3m-Myeloid-monocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.38e-04 | 168 | 80 | 4 | 8ee57814c7e9d45444f48b6b269c4d535bc4d5e1 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.38e-04 | 168 | 80 | 4 | fa0d251693935116adf633d02b7ec4a295100865 | |
| ToppCell | facs-Heart-RV-3m-Myeloid|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.38e-04 | 168 | 80 | 4 | c1a5f4f4d32a1f8583048db709a7037cc9357ad8 | |
| ToppCell | facs-Heart-RV-3m-Myeloid-monocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.38e-04 | 168 | 80 | 4 | a405f0de70293f68b4e000c1fc8a9ad33d56539a | |
| ToppCell | droplet-Heart-nan-3m-Hematologic-leukocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.38e-04 | 168 | 80 | 4 | a4eebc78babb9b5ef33065b0642793820195a613 | |
| ToppCell | droplet-Heart-nan-24m-Hematologic-leukocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.43e-04 | 169 | 80 | 4 | 018f82b3271f90e29c29e2d733d5ced6919fc42e | |
| Disease | polyunsaturated fatty acid measurement | 2.29e-05 | 131 | 76 | 5 | EFO_0010733 | |
| Disease | monounsaturated fatty acids; 16:1, 18:1 measurement | 5.02e-05 | 78 | 76 | 4 | EFO_0022187 | |
| Disease | cholesteryl ester measurement, intermediate density lipoprotein measurement | 1.04e-04 | 94 | 76 | 4 | EFO_0008595, EFO_0010351 | |
| Disease | cholesteryl esters to total lipids in medium LDL percentage | 1.20e-04 | 37 | 76 | 3 | EFO_0022252 | |
| Disease | linoleic acid measurement | 1.21e-04 | 186 | 76 | 5 | EFO_0006807 | |
| Disease | platelet component distribution width | 1.38e-04 | 755 | 76 | 9 | EFO_0007984 | |
| Disease | lipoprotein-associated phospholipase A(2) measurement | 1.51e-04 | 40 | 76 | 3 | EFO_0004746 | |
| Disease | familial hyperlipidemia | 1.65e-04 | 106 | 76 | 4 | MONDO_0001336 | |
| Disease | chylomicron measurement, very low density lipoprotein cholesterol measurement | 1.65e-04 | 106 | 76 | 4 | EFO_0008317, EFO_0008596 | |
| Disease | cholesteryl esters to total lipids in small LDL percentage | 1.75e-04 | 42 | 76 | 3 | EFO_0022255 | |
| Disease | chylomicron measurement, very low density lipoprotein cholesterol measurement, phospholipid measurement | 1.84e-04 | 109 | 76 | 4 | EFO_0004639, EFO_0008317, EFO_0008596 | |
| Disease | free cholesterol to total lipids in very small VLDL percentage | 1.88e-04 | 43 | 76 | 3 | EFO_0022290 | |
| Disease | cholesteryl ester measurement, chylomicron measurement, very low density lipoprotein cholesterol measurement | 1.91e-04 | 110 | 76 | 4 | EFO_0008317, EFO_0008596, EFO_0010351 | |
| Disease | free cholesterol measurement, chylomicron measurement, very low density lipoprotein cholesterol measurement | 1.91e-04 | 110 | 76 | 4 | EFO_0008317, EFO_0008591, EFO_0008596 | |
| Disease | chylomicron measurement, total cholesterol measurement, very low density lipoprotein cholesterol measurement | 1.91e-04 | 110 | 76 | 4 | EFO_0004574, EFO_0008317, EFO_0008596 | |
| Disease | total lipids in very small VLDL measurement | 2.16e-04 | 45 | 76 | 3 | EFO_0022156 | |
| Disease | saturated fatty acids measurement | 2.16e-04 | 45 | 76 | 3 | EFO_0022304 | |
| Disease | low density lipoprotein cholesterol measurement, lipid measurement | 2.19e-04 | 114 | 76 | 4 | EFO_0004529, EFO_0004611 | |
| Disease | free cholesterol in small VLDL measurement | 2.45e-04 | 47 | 76 | 3 | EFO_0022272 | |
| Disease | free cholesterol in very small VLDL measurement | 2.45e-04 | 47 | 76 | 3 | EFO_0022275 | |
| Disease | free cholesterol in medium VLDL measurement | 2.45e-04 | 47 | 76 | 3 | EFO_0022269 | |
| Disease | ocular hypertension, response to triamcinolone acetonide | 2.78e-04 | 49 | 76 | 3 | EFO_0006954, EFO_1001069 | |
| Disease | oleoyl-linoleoyl-glycerol (18:1/18:2) [2] measurement | 2.91e-04 | 10 | 76 | 2 | EFO_0800333 | |
| Disease | polyunsaturated fatty acids to total fatty acids percentage | 2.95e-04 | 50 | 76 | 3 | EFO_0022303 | |
| Disease | phospholipids in very small VLDL measurement | 3.13e-04 | 51 | 76 | 3 | EFO_0022300 | |
| Disease | polyunsaturated fatty acids to monounsaturated fatty acids ratio | 3.13e-04 | 51 | 76 | 3 | EFO_0022302 | |
| Disease | cholesterol to total lipids in small HDL percentage | 3.13e-04 | 51 | 76 | 3 | EFO_0022240 | |
| Disease | cholesteryl ester measurement, low density lipoprotein cholesterol measurement | 3.21e-04 | 126 | 76 | 4 | EFO_0004611, EFO_0010351 | |
| Disease | phospholipids in medium VLDL measurement | 3.31e-04 | 52 | 76 | 3 | EFO_0022154 | |
| Disease | total phospholipids in lipoprotein particles measurement | 3.51e-04 | 53 | 76 | 3 | EFO_0022315 | |
| Disease | triglycerides in HDL measurement | 3.51e-04 | 53 | 76 | 3 | EFO_0022317 | |
| Disease | cholesterol in small VLDL measurement | 3.51e-04 | 53 | 76 | 3 | EFO_0022228 | |
| Disease | free cholesterol to total lipids in small LDL percentage | 3.51e-04 | 53 | 76 | 3 | EFO_0022286 | |
| Disease | total lipids in medium VLDL | 3.71e-04 | 54 | 76 | 3 | EFO_0022153 | |
| Disease | triglycerides in medium HDL measurement | 3.71e-04 | 54 | 76 | 3 | EFO_0022321 | |
| Disease | triglycerides in LDL measurement | 4.13e-04 | 56 | 76 | 3 | EFO_0022320 | |
| Disease | triglycerides to total lipids in medium HDL percentage | 4.13e-04 | 56 | 76 | 3 | EFO_0022333 | |
| Disease | cholesteryl esters to total lipids in medium HDL percentage | 4.13e-04 | 56 | 76 | 3 | EFO_0022251 | |
| Disease | free cholesterol measurement, low density lipoprotein cholesterol measurement | 4.40e-04 | 137 | 76 | 4 | EFO_0004611, EFO_0008591 | |
| Disease | triglycerides in IDL measurement | 4.58e-04 | 58 | 76 | 3 | EFO_0022149 | |
| Disease | triglycerides to total lipids in small LDL percentage | 4.81e-04 | 59 | 76 | 3 | EFO_0022337 | |
| Disease | phospholipids in VLDL measurement | 4.81e-04 | 59 | 76 | 3 | EFO_0022301 | |
| Disease | tetralogy of Fallot (is_implicated_in) | 5.01e-04 | 13 | 76 | 2 | DOID:6419 (is_implicated_in) | |
| Disease | Nephronophthisis | 5.01e-04 | 13 | 76 | 2 | C0687120 | |
| Disease | phospholipids in small VLDL measurement | 5.06e-04 | 60 | 76 | 3 | EFO_0022146 | |
| Disease | total lipids in IDL | 5.06e-04 | 60 | 76 | 3 | EFO_0022161 | |
| Disease | triglycerides to total lipids in large HDL percentage | 5.06e-04 | 60 | 76 | 3 | EFO_0022330 | |
| Disease | cholesterol in chylomicrons and extremely large VLDL measurement | 5.06e-04 | 60 | 76 | 3 | EFO_0021898 | |
| Disease | total lipids in VLDL measurement | 5.06e-04 | 60 | 76 | 3 | EFO_0022314 | |
| Disease | cholesterol to total lipids in medium HDL percentage | 5.06e-04 | 60 | 76 | 3 | EFO_0022237 | |
| Disease | triglycerides in small VLDL measurement | 5.31e-04 | 61 | 76 | 3 | EFO_0022145 | |
| Disease | free cholesterol in IDL measurement | 5.31e-04 | 61 | 76 | 3 | EFO_0022181 | |
| Disease | free cholesterol in very large VLDL measurement | 5.31e-04 | 61 | 76 | 3 | EFO_0022274 | |
| Disease | free cholesterol in VLDL measurement | 5.31e-04 | 61 | 76 | 3 | EFO_0022276 | |
| Disease | chylomicron measurement, very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | 5.31e-04 | 61 | 76 | 3 | EFO_0008317, EFO_0008596, EFO_0020946 | |
| Disease | cholesterol:total lipids ratio, low density lipoprotein cholesterol measurement | 5.31e-04 | 144 | 76 | 4 | EFO_0004611, EFO_0020943 | |
| Disease | triglycerides in small HDL measurement | 5.57e-04 | 62 | 76 | 3 | EFO_0022158 | |
| Disease | phospholipids in large VLDL measurement | 5.57e-04 | 62 | 76 | 3 | EFO_0022169 | |
| Disease | triglycerides in medium LDL measurement | 5.57e-04 | 62 | 76 | 3 | EFO_0022322 | |
| Disease | triglycerides to total lipids in very large HDL percentage | 5.57e-04 | 62 | 76 | 3 | EFO_0022339 | |
| Disease | free cholesterol in very large HDL measurement | 5.57e-04 | 62 | 76 | 3 | EFO_0022273 | |
| Disease | free cholesterol in chylomicrons and extremely large VLDL measurement | 5.57e-04 | 62 | 76 | 3 | EFO_0022263 | |
| Disease | phospholipids in very large VLDL measurement | 5.57e-04 | 62 | 76 | 3 | EFO_0022299 | |
| Disease | triglycerides to total lipids in medium VLDL percentage | 5.83e-04 | 63 | 76 | 3 | EFO_0022335 | |
| Disease | cholesterol to total lipids in medium VLDL percentage | 5.83e-04 | 63 | 76 | 3 | EFO_0022239 | |
| Disease | free cholesterol to total lipids in medium LDL percentage | 5.83e-04 | 63 | 76 | 3 | EFO_0022283 | |
| Disease | cholesteryl esters to total lipids in medium VLDL percentage | 6.11e-04 | 64 | 76 | 3 | EFO_0022253 | |
| Disease | triglycerides in small LDL measurement | 6.39e-04 | 65 | 76 | 3 | EFO_0022323 | |
| Disease | cholesterol in large VLDL measurement | 6.39e-04 | 65 | 76 | 3 | EFO_0021902 | |
| Disease | cholesterol in very large VLDL measurement | 6.39e-04 | 65 | 76 | 3 | EFO_0022230 | |
| Disease | obsolete_red blood cell distribution width | LONP1 ST3GAL5 LPL BACH1 MECOM DHDDS MAFB IRS2 CHD4 ST7L ZBTB24 | 6.46e-04 | 1347 | 76 | 11 | EFO_0005192 |
| Disease | low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | 6.67e-04 | 153 | 76 | 4 | EFO_0004611, EFO_0020946 | |
| Disease | low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio | 6.67e-04 | 153 | 76 | 4 | EFO_0004611, EFO_0020944 | |
| Disease | total lipids in small VLDL | 6.99e-04 | 67 | 76 | 3 | EFO_0022148 | |
| Disease | cholesterol to total lipids in very small VLDL percentage | 6.99e-04 | 67 | 76 | 3 | EFO_0022245 | |
| Disease | triglycerides in very small VLDL measurement | 7.30e-04 | 68 | 76 | 3 | EFO_0022144 | |
| Disease | triglycerides to phosphoglycerides ratio | 7.30e-04 | 68 | 76 | 3 | EFO_0022327 | |
| Disease | free cholesterol in large VLDL measurement | 7.30e-04 | 68 | 76 | 3 | EFO_0022265 | |
| Disease | triglycerides to total lipids in very small VLDL percentage | 7.61e-04 | 69 | 76 | 3 | EFO_0022341 | |
| Disease | triglycerides to total lipids in small HDL percentage | 8.62e-04 | 72 | 76 | 3 | EFO_0022336 | |
| Disease | triglyceride measurement, low density lipoprotein cholesterol measurement | 9.04e-04 | 166 | 76 | 4 | EFO_0004530, EFO_0004611 | |
| Disease | free cholesterol to total lipids in large LDL percentage | 9.33e-04 | 74 | 76 | 3 | EFO_0022280 | |
| Disease | free cholesterol to total lipids in small VLDL percentage | 9.70e-04 | 75 | 76 | 3 | EFO_0022287 | |
| Disease | cardiovascular disease | 1.17e-03 | 457 | 76 | 6 | EFO_0000319 | |
| Disease | mean platelet volume | 1.22e-03 | 1020 | 76 | 9 | EFO_0004584 | |
| Disease | disease of metabolism (implicated_via_orthology) | 1.33e-03 | 21 | 76 | 2 | DOID:0014667 (implicated_via_orthology) | |
| Disease | reticulocyte count | 1.44e-03 | 1045 | 76 | 9 | EFO_0007986 | |
| Disease | lipid measurement, lipoprotein measurement | 1.64e-03 | 90 | 76 | 3 | EFO_0004529, EFO_0004732 | |
| Disease | omega-6 polyunsaturated fatty acid measurement | 1.70e-03 | 197 | 76 | 4 | EFO_0005680 | |
| Disease | Dyslipidemias | 1.74e-03 | 24 | 76 | 2 | C0242339 | |
| Disease | Dyslipoproteinemias | 1.74e-03 | 24 | 76 | 2 | C0598784 | |
| Disease | chylomicron measurement, very low density lipoprotein cholesterol measurement, lipid measurement | 1.92e-03 | 95 | 76 | 3 | EFO_0004529, EFO_0008317, EFO_0008596 | |
| Disease | chylomicron measurement, triglyceride measurement, very low density lipoprotein cholesterol measurement | 1.98e-03 | 96 | 76 | 3 | EFO_0004530, EFO_0008317, EFO_0008596 | |
| Disease | lipid measurement, intermediate density lipoprotein measurement | 1.98e-03 | 96 | 76 | 3 | EFO_0004529, EFO_0008595 | |
| Disease | triglycerides:total lipids ratio, high density lipoprotein cholesterol measurement | 2.00e-03 | 206 | 76 | 4 | EFO_0004612, EFO_0020947 | |
| Disease | myocardial infarction | 2.12e-03 | 350 | 76 | 5 | EFO_0000612 | |
| Disease | triglyceride measurement, alcohol drinking | 2.16e-03 | 99 | 76 | 3 | EFO_0004329, EFO_0004530 | |
| Disease | total cholesterol measurement, intermediate density lipoprotein measurement | 2.16e-03 | 99 | 76 | 3 | EFO_0004574, EFO_0008595 | |
| Disease | neurotic disorder | 2.28e-03 | 101 | 76 | 3 | EFO_0004257 | |
| Disease | triglyceride measurement, alcohol consumption measurement | 2.28e-03 | 101 | 76 | 3 | EFO_0004530, EFO_0007878 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| NKNVQTPQCKLRRYQ | 176 | O14867 | |
| RLIGNLCYKNKDNQD | 376 | Q9UBB4 | |
| RQQVQLKAECNKGYV | 56 | Q7Z2E3 | |
| RCNKKDGFYRQVNQI | 171 | Q9NZJ0 | |
| YSCGINRENQQFKKE | 191 | Q6ZUS5 | |
| CNETYKKRQLFRGNR | 321 | Q9UBL0 | |
| RQILQKYSYCRQKIQ | 321 | Q9NS23 | |
| CYTLQEENKQLRRAG | 391 | A6NNM3 | |
| CYTLQEENKQLRRAG | 391 | A6NJZ7 | |
| RARKLATNNECVYGN | 6 | Q03112 | |
| NLRKAKQGYVQRCED | 401 | Q92619 | |
| QKRRTLKNRGYAQSC | 241 | Q9Y5Q3 | |
| QKRRTLKNRGYAQSC | 291 | O75444 | |
| REIVKLCSQYQNQAK | 291 | Q9NQ38 | |
| RNFGKKNTKQAYVQC | 521 | Q8WVS4 | |
| RKNRCNNLGYEINKV | 306 | P06858 | |
| NKKNCRTNISYGLEN | 671 | Q9UHC1 | |
| KKQTQRNVFRCNVIG | 411 | Q8IXI2 | |
| QGNCQEKSEIRLYRQ | 2121 | O15018 | |
| KRGLVLRNEKCNENY | 621 | P08237 | |
| KNNRLYQVSVGQCLR | 566 | Q8NCW6 | |
| QDRLKACQQREGQNY | 101 | O96000 | |
| RDAYQQKLVQLQEKC | 831 | Q5T1M5 | |
| DQCNVYNSGQRRKLL | 536 | Q1KMD3 | |
| QLRKANDQSGRCQYT | 36 | Q99972 | |
| VQQSCNYKQLRKGAN | 26 | P55769 | |
| KQYCRESGVRNLQKQ | 701 | P36776 | |
| QQECKLLYSRKEGQR | 256 | Q06124 | |
| YDQCKKRGTKTQNLR | 226 | Q8TDV0 | |
| FQNRRYKCKRQRQDQ | 186 | P52952 | |
| FKNRRAKCRQQQQSG | 86 | P32242 | |
| KESQRLEKQYCTQVN | 476 | Q16827 | |
| NNNHSVRKCGYLRKQ | 26 | Q9Y4H2 | |
| FRRSIQQNIQYKRCL | 156 | P20393 | |
| KSQADQFCQRLGKYR | 381 | Q96N67 | |
| LQQQKICRNRARKYF | 61 | Q9P2H0 | |
| KQIAKCQQLQQEYSR | 131 | Q96JB5 | |
| RQQQHKQNKQVLGYC | 146 | Q9NNZ3 | |
| RVERLQKIQNAYSKC | 61 | Q8WYH8 | |
| VTQRNKNYEVLCRNR | 266 | Q5VTH9 | |
| YQLEGNKRITCRNGQ | 241 | Q03591 | |
| GKRIRKQVNYNDGSQ | 1336 | Q14839 | |
| NRRYAKKCQVERQEG | 36 | Q86SQ9 | |
| YQRCIQLKQAIDENK | 46 | O15259 | |
| GKINCLRNCKTYQAR | 386 | O94955 | |
| QYRNGTQLRKICKDD | 401 | A6NHM9 | |
| FFRRSIQQNIQYKKC | 126 | Q14995 | |
| KRTVQNNKRYTCIEN | 111 | O00482 | |
| QNCQIDKTQRKRCPY | 126 | O00482 | |
| NARSVCGKQRSKQLY | 16 | Q9NP80 | |
| CGRRDVSYNNAKQKE | 161 | Q5TD94 | |
| KRERNQQLDLCKGGY | 146 | P78337 | |
| IAKERQKQYNCLTQR | 191 | Q9Y3A2 | |
| QKQYNCLTQRIEREK | 196 | Q9Y3A2 | |
| LQSETVQYKRGVCQQ | 156 | Q96PX1 | |
| RVHRCVGNYDQKKNI | 311 | Q8NHS9 | |
| KGCQNKEQILQQRFR | 3056 | Q8NF91 | |
| CYTLQAENKQLRRAG | 391 | Q9UFD9 | |
| KRAQKYAQQVLQKEC | 106 | Q9UNP4 | |
| CDYRTQNVLGLQKQI | 681 | Q562F6 | |
| NKVCNRYEFLNGRVQ | 726 | P00747 | |
| RYVKQQCRQADKYQP | 236 | Q17RW2 | |
| KDQEYTQLCRNINRV | 3076 | Q63HN8 | |
| FCRSRGNLVVQNKQK | 516 | Q9UNS1 | |
| ACARRIVQNSNGYKI | 111 | O60701 | |
| RTVNEGKGQKEYCNR | 71 | Q5SXM1 | |
| YCHCRERQKLGKNQQ | 801 | A4D1E1 | |
| KQLLGENYRNNRKNI | 806 | Q9Y5Y9 | |
| KGKRANSQENRNYLR | 991 | Q6ZT07 | |
| EKCNQRTQKRKIYNV | 6 | Q6U7Q0 | |
| LKAGETIYRQSQQCQ | 261 | Q8TDW4 | |
| KKVQKNRNNYASVEC | 301 | Q9UBS9 | |
| DQCGKYFSQNRQLKS | 381 | O43167 | |
| NVRVYNTVNGKQKKC | 651 | O43379 | |
| VQEGNKSSVQKQYRC | 746 | Q8TCN5 | |
| YRCKGKNVRVQAQEN | 101 | Q8N3Z6 | |
| KSYKGEGRQQICNQQ | 151 | Q7Z2W4 | |
| KEGYNELNQCLRTTQ | 136 | Q8NEM1 | |
| KQKAEAQRRLYGQNS | 391 | Q6ZT98 | |
| QDVKRFYRKLCNNTD | 71 | B1ANS9 | |
| KEGYNKLNQCRTATQ | 136 | A6NN14 | |
| NENTGQRYKNISCKI | 541 | Q7Z570 |